New immunotherapy treatment offering fresh hope for Kentucky cancer patients
About this episode
Dr. Greg discusses a new immunotherapy treatment for small cell lung cancer with Dr. Zhonglin Hao from the University of Kentucky Markey Cancer Center.
The University of Kentucky Markey Cancer Center has treated the first patient in the U.S. with a new immunotherapy for small cell lung cancer, offering hope for patients whose cancers have stopped responding to other treatments. Dr. Greg talks with Markey Cancer Center medical oncologist Zhonglin Hao, M.D., Ph.D.
More episodes of Dr. Greg Davis on Medicine
- Bike/Walk month encourages us all to 'put our best foot forward' while sharing the road
- 'Stop the Bleed' event to empower public with invaluable, potentially life-saving skill
- Dr. Greg: sowing seeds of safety: staying healthy and injury-free when working outdoors
- UK study: ‘Person-centered care’ improves lives of dementia residents, caregivers
- Kentucky's top state health official acts to counter mixed messages coming out of DC
- World Hearing Day 5K helps patients offset the cost of hearing aids
Explore listener stats, chart rankings, contacts and more on the Dr. Greg Davis on Medicine podcast page.